Release Date: 25/09/18 17:08 Summary: Third Supplementary Bidder's Statement & Variation of Offer Price Sensitive: Yes Download Document 373.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%